EVALUATION OF THE THERAPEUTIC EFFECTS OF SALVIA ROSMARINUS ON NERVOUS SYSTEM DISORDERS

Malina Mihaela Visternicu; Viorica Rarinca; Vasile Burlui; Alin Ciobica

doi:10.47743/jemb-2025-214

Authors

Malina Mihaela Visternicu Doctoral School of Biology, Faculty of Biology, “Alexandru Ioan Cuza” University of Iași, Carol I Avenue, 20A, Iasi, Romania
Viorica Rarinca Alexandru Ioan Cuza University
Vasile Burlui Apollonia University
Alin Ciobica Alexandru Ioan Cuza University

DOI:

https://doi.org/10.47743/jemb-2025-214

Keywords:

Salvia rosmarinus, nervous system disorders, neuroprotective effect, memory, ADHD, Alzheimer, Parkinson, epilepsy MDD

Abstract

Rosemary (Salvia rosmarinus Spenn) is an aromatic plant that has been used for centuries in traditional medicine for its remarkable therapeutic properties. Rosemary contains bioactive compounds with antioxidant, anti-inflammatory, and neuroprotective actions, and it is recognized for its beneficial effects on mental and cognitive health. This review explores the therapeutic potential of rosemary in alleviating nervous system disorders such as Alzheimer's disease (AD), major depressive disorder (MDD), epilepsy, Parkinson's disease (PD), addiction, and attention-deficit hyperactivity disorder (ADHD). Preclinical and clinical research suggests that rosemary extracts, through their active compounds, may enhance cognitive function, protect neurons from oxidative stress, and modulate neurotransmitters involved in cognitive and emotional processes. The findings indicate that rosemary could be a promising complementary therapy in managing nervous system disorders, offering significant benefits for mental and neurological health. However, further studies are needed to fully understand the efficacy and safety of long-term use.

References

Abdelrazik E, Hassan HM, Hamza E, Ezz Elregal FM, Elnagdy MH, Abdulhai EA. 2023. Beneficial role of rosemary extract on oxidative stress-mediated neuronal apoptosis in rotenone-induced attention deficit hyperactivity disease in juvenile rat model. Acta Biomedica. 94(3). doi:10.23750/abm.v94i3.14260.

Achour M, Ben Salem I, Ferdousi F, Nouira M, Ben Fredj M, Mtiraoui A, Isoda H, Saguem S. 2022. Rosemary Tea Consumption Alters Peripheral Anxiety and Depression Biomarkers: A Pilot Study in Limited Healthy Volunteers. Journal of the American Nutrition Association. 41(3). doi:10.1080/07315724.2021.1873871.

Al-Tawarah NM, Al-dmour RH, Abu Hajleh MN, Khleifat KM, Alqaraleh M, Al-Saraireh YM, Jaradat AQ, Al-Dujaili EAS. 2023. Rosmarinus officinalis and Mentha piperita Oils Supplementation Enhances Memory in a Rat Model of Scopolamine-Induced Alzheimer’s Disease-like Condition. Nutrients. 15(6). doi:10.3390/nu15061547.

Andrade JM, Faustino C, Garcia C, Ladeiras D, Reis CP, Rijo P. 2018. Rosmarinus officinalis L.: An update review of its phytochemistry and biological activity. Future Sci OA. 4(4). doi:10.4155/fsoa-2017-0124.

Aruoma OI, Halliwell B, Aeschbach R, Löligers J. 1992. Antioxidant and pro-oxidant properties of active Rosemary constituents: Carnosol and carnosic acid. Xenobiotica. 22(2). doi:10.3109/00498259209046624.

Ayaz M, Sadiq A, Junaid M, Ullah F, Subhan F, Ahmed J. 2017. Neuroprotective and anti-aging potentials of essential oils from aromatic and medicinal plants. Front Aging Neurosci. 9(MAY). doi:10.3389/fnagi.2017.00168.

Azizi S, Mohamadi N, Sharififar F, Dehghannoudeh G, Jahanbakhsh F, Dabaghzadeh F. 2022. Rosemary as an adjunctive treatment in patients with major depressive disorder: A randomized, double‐blind, placebo‐controlled trial. Complement Ther Clin Pract. 49. doi:10.1016/j.ctcp.2022.101685.

Capatina L, Boiangiu RS, Dumitru G, Napoli EM, Ruberto G, Hritcu L, Todirascu-Ciornea E. 2020. Rosmarinus officinalis essential oil improves scopolamine-induced neurobehavioral changes via restoration of cholinergic function and brain antioxidant status in Zebrafish (Danio rerio). Antioxidants. 9(1). doi:10.3390/antiox9010062.

Faridzadeh A, Salimi Y, Ghasemirad H, Kargar M, Rashtchian A, Mahmoudvand G, Karimi MA, Zerangian N, Jahani N, Masoudi A, et al. 2022. Neuroprotective Potential of Aromatic Herbs: Rosemary, Sage, and Lavender. Front Neurosci. 16. doi:10.3389/fnins.2022.909833.

Fernandes F, Barroso MF, De Simone A, Emriková E, Dias-Teixeira M, Pereira JP, Chlebek J, Fernandes VC, Rodrigues F, Andrisano V, et al. 2022. Multi-target neuroprotective effects of herbal medicines for Alzheimer’s disease. J Ethnopharmacol. 290. doi:10.1016/j.jep.2022.115107.

Filiptsova OV, Gazzavi-Rogozina LV, Timoshyna IA, Naboka OI, Dyomina YeV, Ochkur AV. 2017. The essential oil of rosemary and its effect on the human image and numerical short-term memory. Egyptian Journal of Basic and Applied Sciences. 4(2). doi:10.1016/j.ejbas.2017.04.002.

Hashemi SMB, Gholamhosseinpour A, Barba FJ. 2023. Rosmarinus officinalis L. Essential Oils Impact on the Microbiological and Oxidative Stability of Sarshir (Kaymak). Molecules. 28(10). doi:10.3390/molecules28104206.

Heilig M, MacKillop J, Martinez D, Rehm J, Leggio L, Vanderschuren LJMJ. 2021. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. 46(10). doi:10.1038/s41386-020-00950-y.

Jimbo D, Kimura Y, Taniguchi M, Inoue M, Urakami K. 2009. Effect of aromatherapy on patients with Alzheimer’s disease. Psychogeriatrics. 9(4). doi:10.1111/j.1479-8301.2009.00299.x.

Khwaza V, Oyedeji OO, Aderibigbe BA. 2018. Antiviral activities of oleanolic acid and its analogues. Molecules. 23(9). doi:10.3390/molecules23092300.

Kim G, Dasagrandhi C, Kang EH, Eom SH, Kim YM. 2018. In vitro antibacterial and early-stage biofilm inhibitory potential of an edible chitosan and its phenolic conjugates against Pseudomonas aeruginosa and Listeria monocytogenes. 3 Biotech. 8(10). doi:10.1007/s13205-018-1451-4.

Kim SJ, Kim JS, Cho HS, Lee HJ, Kim SY, Kim S, Lee SY, Chun HS. 2006. Carnosol, a component of rosemary (Rosmarinus officinalis L.) protects nigral dopaminergic neuronal cells. Neuroreport. 17(16). doi:10.1097/01.wnr.0000239951.14954.10.

Kosmopoulou D, Lafara MP, Adamantidi T, Ofrydopoulou A, Grabrucker AM, Tsoupras A. 2024. Neuroprotective Benefits of Rosmarinus officinalis and Its Bioactives against Alzheimer’s and Parkinson’s Diseases. Applied Sciences (Switzerland). 14(15). doi:10.3390/app14156417.

Krendl AC, Perry BL. 2023. Stigma Toward Substance Dependence: Causes, Consequences, and Potential Interventions. Psychological Science in the Public Interest. 24(2). doi:10.1177/15291006231198193.

Lee DY, Hwang CJ, Choi JY, Park MH, Song MJ, Oh KW, Son DJ, Lee SH, Han SB, Hong JT. 2017. Inhibitory effect of carnosol on phthalic anhydride-induced atopic dermatitis via inhibition of STAT3. Biomol Ther (Seoul). 25(5). doi:10.4062/biomolther.2017.006.

Leffa DT, Caye A, Rohde LA. 2022. ADHD in Children and Adults: Diagnosis and Prognosis. In: Current Topics in Behavioral Neurosciences. Vol. 57.

Li M, Cui MM, Kenechukwu N, Gu YW, Chen YL, Zhong SJ, Gao YT, Cao XY, Wang L, Liu FM, et al. 2020. Rosmarinic acid ameliorates hypoxia/ischemia induced cognitive deficits and promotes remyelination. Neural Regen Res. 15(5). doi:10.4103/1673-5374.268927.

Li Pomi F, Papa V, Borgia F, Vaccaro M, Allegra A, Cicero N, Gangemi S. 2023. Rosmarinus officinalis and Skin: Antioxidant Activity and Possible Therapeutical Role in Cutaneous Diseases. Antioxidants. 12(3). doi:10.3390/antiox12030680.

Lin KI, Lin CC, Kuo SM, Lai JC, Wang YQ, You HL, Hsu ML, Chen CH, Shiu LY. 2018. Carnosic acid impedes cell growth and enhances anticancer effects of carmustine and lomustine in melanoma. Biosci Rep. 38(4). doi:10.1042/BSR20180005.

Liu J, Hull V, Godfray HCJ, Tilman D, Gleick P, Hoff H, Pahl-Wostl C, Xu Z, Chung MG, Sun J, et al. 2018. Nexus approaches to global sustainable development. Nat Sustain. 1(9). doi:10.1038/s41893-018-0135-8.

López-Martín S, Albert J, Calleja-Pérez B, Fernández-Mayoralas DM, Fernández-Perrone AL, de Domingo AJ, Fernández-Jaén A. 2024. Genetics of ADHD in clinical practice. Medicina (B Aires). 84.

Ložienė K, Švedienė J, Paškevičius A, Raudonienė V, Sytar O, Kosyan A. 2018. Influence of plant origin natural α-pinene with different enantiomeric composition on bacteria, yeasts, and fungi. Fitoterapia. 127. doi:10.1016/j.fitote.2018.04.013.

de Macedo LM, Dos Santos ÉM, Militão L, Tundisi LL, Ataide JA, Souto EB, Mazzola PG. 2020. Rosemary (Rosmarinus officinalis L., syn salvia rosmarinus spenn.) and its topical applications: A review. Plants. 9(5). doi:10.3390/plants9050651.

Malik N, Amber S, Zahid S. 2022. Rosmarinus officinalis and Methylphenidate Exposure Improves Cognition and Depression and Regulates Anxiety-Like Behavior in AlCl3-Induced Mouse Model of Alzheimer’s Disease. Front Pharmacol. 13. doi:10.3389/fphar.2022.943163.

Micić D, Ðurović S, Riabov P, Tomić A, Šovljanski O, Filip S, Tosti T, Dojčinović B, Božović R, Jovanović D, et al. 2021. Rosemary essential oils as a promising source of bioactive compounds: Chemical composition, thermal properties, biological activity, and gastronomical perspectives. Foods. 10(11). doi:10.3390/foods10112734.

Murata K, Noguchi K, Kondo M, Onishi M, Watanabe N, Okamura K, Matsuda H. 2013. Promotion of hair growth by rosmarinus officinalis leaf extract. Phytotherapy Research. 27(2). doi:10.1002/ptr.4712.

Nematolahi P, Mehrabani M, Karami-Mohajeri S, Dabaghzadeh F. 2018. Effects of Rosmarinus officinalis L. on memory performance, anxiety, depression, and sleep quality in university students: A randomized clinical trial. Complement Ther Clin Pract. 30. doi:10.1016/j.ctcp.2017.11.004.

Neves Josynaria Araújo, Neves Josyanne Araújo, Oliveira R de CM. 2018. Pharmacological and biotechnological advances with Rosmarinus officinalis L. Expert Opin Ther Pat. 28(5). doi:10.1080/13543776.2018.1459570.

Nishizawa D, Ikeda K. 2015. Substance dependence and genetic polymorphisms. Nihon Rinsho. 73(9).

De Oliveira JR, Camargo SEA, De Oliveira LD. 2019. Rosmarinus officinalis L. (rosemary) as therapeutic and prophylactic agent. J Biomed Sci. 26(1). doi:10.1186/s12929-019-0499-8.

Oresanya IO, Orhan IE. 2024. Deciphering Neuroprotective Effect of Rosmarinus officinalis L. (syn. Salvia rosmarinus Spenn.) through Preclinical and Clinical Studies. Curr Drug Targets. 25(5). doi:10.2174/0113894501255093240117092328.

Ozarowski M, Mikolajczak PL, Bogacz A, Gryszczynska A, Kujawska M, Jodynis-Liebert J, Piasecka A, Napieczynska H, Szulc M, Kujawski R, et al. 2013. Rosmarinus officinalis L. leaf extract improves memory impairment and affects acetylcholinesterase and butyrylcholinesterase activities in rat brain. Fitoterapia. 91. doi:10.1016/j.fitote.2013.09.012.

Patil KR, Mahajan UB, Unger BS, Goyal SN, Belemkar S, Surana SJ, Ojha S, Patil CR. 2019. Animal models of inflammation for screening of anti-inflammatory drugs: Implications for the discovery and development of phytopharmaceuticals. Int J Mol Sci. 20(18). doi:10.3390/ijms20184367.

Pengelly A, Snow J, Mills SY, Scholey A, Wesnes K, Butler LR. 2012. Short-term study on the effects of rosemary on cognitive function in an elderly population. J Med Food. 15(1). doi:10.1089/jmf.2011.0005.

Pferschy-Wenzig EM, Pausan MR, Ardjomand-Woelkart K, Röck S, Ammar RM, Kelber O, Moissl-Eichinger C, Bauer R. 2022. Medicinal Plants and Their Impact on the Gut Microbiome in Mental Health: A Systematic Review. Nutrients. 14(10). doi:10.3390/nu14102111.

Rahbardar MG, Hosseinzadeh H. 2020. Therapeutic effects of rosemary (Rosmarinus officinalis L.) and its active constituents on nervous system disorders. Iran J Basic Med Sci. 23(9). doi:10.22038/ijbms.2020.45269.10541.

Rašković A, Milanović I, Pavlović N, Ćebović T, Vukmirović S, Mikov M. 2014. Antioxidant activity of rosemary (Rosmarinus officinalis L.) essential oil and its hepatoprotective potential. BMC Complement Altern Med. 14. doi:10.1186/1472-6882-14-225.

Saleh A, Al Kamaly O, Alanazi AS, Noman O. 2022. Phytochemical Analysis and Antimicrobial Activity of Rosmarinus officinalis L. Growing in Saudi Arabia: Experimental and Computational Approaches. Processes. 10(11). doi:10.3390/pr10112422.

Sasaki K, El Omri A, Kondo S, Han J, Isoda H. 2013. Rosmarinus officinalis polyphenols produce anti-depressant like effect through monoaminergic and cholinergic functions modulation. Behavioural Brain Research. 238(1). doi:10.1016/j.bbr.2012.10.010.

Schmidt D. 2009. Drug treatment of epilepsy: Options and limitations. Epilepsy and Behavior. 15(1). doi:10.1016/j.yebeh.2009.02.030.

Sharmila R, Manoharan S. 2012. Anti-tumor activity of rosmarinic acid in 7,12-dimethylbenz(a)anthracene (DMBA) induced skin carcinogenesis in Swiss albino mice. Indian J Exp Biol. 50(3).

Singleman C, Holtzman NG. 2014. Growth and maturation in the zebrafish, Danio Rerio: A staging tool for teaching and research. Zebrafish. 11(4). doi:10.1089/zeb.2014.0976.

Skipper C, Birkmayer F. 2018. The Role of Aromatherapy in the Treatment of Substance Use and Co-Occurring Disorders. In: Modir SJ, Muñoz GE, editors. Integrative Addiction and Recovery. Oxford University PressNew York. p. 415–422.

Solhi H, Salehi B, Alimoradian A, Pazouki S, Taghizadeh M, Mohammad Saleh A, Mohammad Kazemifar A. 2013. Beneficial Effects of Rosmarinus Officinalis for Treatment of Opium Withdrawal Syndrome during Addiction Treatment Programs: A Clinical Trial. http://ahj.kmu.ac.ir,7October.

Stoker TB, Barker RA. 2020. Recent developments in the treatment of Parkinson’s Disease. F1000Res. 9. doi:10.12688/f1000research.25634.1.

Teixeira L. 2024. The nervous system and associated disorders. British Journal of Nursing. 33(4). doi:10.12968/bjon.2024.33.4.194.

Umasankar K, Nambikkairaj B, Manley Backyavathy D. 2012. Effect of topical treatment of rosmarinus officinalis essential oil on wound healing in streptozotocin induced diabetic rats. Nature Environment and Pollution Technology. 11(4).

Wenthur CJ. 2016. Classics in Chemical Neuroscience: Methylphenidate. ACS Chem Neurosci. 7(8). doi:10.1021/acschemneuro.6b00199.

Zalsman G, Shilton T. 2016. Adult ADHD: A new disease? Int J Psychiatry Clin Pract. 20(2). doi:10.3109/13651501.2016.1149197.